Patents matching “recombinant”

US 7862821

Recombinant vaccine against bluetongue virus

The Regents of the University of California · Granted Jan 4, 2011 · Expires Dec 30, 2030

US 7846675

Truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi strains karp, kato and gilliam and its use in antibody based detection assays and vaccines

United States of America as represented by the Secretary of the Air Force · Granted Dec 7, 2010 · Expires Dec 2, 2030

US 7820181

Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

The United States of America, as represented by the Department of Health and Human Services · Granted Oct 26, 2010 · Expires Oct 21, 2030

US 7820395

Orientia tsutsugamushi truncated recombinant outer membrane protein (R47) and (R56) vaccines diagnostics and therapeutics for scrub typhus

United States of America as represented by the Secretary of the Air Force · Granted Oct 26, 2010 · Expires Oct 21, 2030

US 7786285

Recombinant vaccine against botulinum neurotoxin

The United States of America as represented by the Secretary of the Army · Granted Aug 31, 2010 · Expires Aug 26, 2030

US 7771715

Recombinant vector expressing multiple costimulatory molecules and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 10, 2010 · Expires Aug 5, 2030

US 7704509

Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

The United States of America · Granted Apr 27, 2010 · Expires Apr 22, 2030

US 7704491

Recombinant human metapneumovirus and its use

The United States of America, as represented by the Department of Health and Human Services · Granted Apr 27, 2010 · Expires Apr 22, 2030

US 7666989

Recombinant protein having an anti-cancer effect, its encoding gene and uses thereof

Beijing Sunbio Biotech Co. Ltd. · Granted Feb 23, 2010 · Expires Feb 18, 2030

US 7638130

Truncated recombinant major outer membrane protein antigen (R56) of Orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines

United States of America as represented by the Secretary of the Air Force · Granted Dec 29, 2009 · Expires Dec 24, 2029

US 7635486

Recombinant lipidated PsaA protein, methods of preparation and use

The United States of America, as represented by the Department of Health and Human Services · Granted Dec 22, 2009 · Expires Dec 17, 2029

US 7632510

Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence

The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Dec 15, 2009 · Expires Dec 10, 2029

US 7622107

Recombinant intracellular pathogen immunogenic compositions and methods for use

The Regents of the University of California · Granted Nov 24, 2009 · Expires Nov 19, 2029

US 7604968

Microorganisms for the recombinant production of resveratrol and other flavonoids

Regents of the University of Minnesota · Granted Oct 20, 2009 · Expires Oct 15, 2029

US 7563883

Recombinant P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army · Granted Jul 21, 2009 · Expires Jul 16, 2029

US 7553931

Complement depletion using recombinant human C3-derivatives

PLS-Design GmbH · Granted Jun 30, 2009 · Expires Jun 25, 2029

US 7544778

Recombinant antigens for diagnosis and prevention of murine typhus

United States of America as represented by the Secretary of the Air Force · Granted Jun 9, 2009 · Expires Jun 4, 2029

US 7541139

Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

The United States of America, as represented by the Department of Health and Human Services · Granted Jun 2, 2009 · Expires May 28, 2029

US 7541034

Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

The United States of America, as represented by the Department of Health and Human Services · Granted Jun 2, 2009 · Expires May 28, 2029

US 7524507

Recombinant microorganisms

The Secretary of State for Defence in Her Brittanic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland · Granted Apr 28, 2009 · Expires Apr 23, 2029

US 7521177

Flavivirus detection methods employing recombinant antigens comprising a Japanese encephalitis (JEV) signal sequence

The United States of America, as represented by the Department of Health and Human Services · Granted Apr 21, 2009 · Expires Apr 16, 2029

US 7465794

Polynucleotides encoding recombinant respiratory syncytial viruses expressing immune modulatory molecules

The United States of America, as represented by the Department of Health and Human Services · Granted Dec 16, 2008 · Expires Dec 11, 2028

US 7446182

Recombinant antibodies for the detection and neutralization of anthrax toxin

The Board of Regents of the University of Texas System · Granted Nov 4, 2008 · Expires Oct 30, 2028

US 7410644

Recombinant pox virus for immunization against tumor-associated antigens

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 12, 2008 · Expires Aug 7, 2028